Abstract:Indoxamycins A-F, a novel class of polyketides, were isolated from the saline culture of marine-derived actinomyces by Sato et al. in 2009. Intriguing stereochemical complexity involving tricyclic [5.5.6] cage-like structures with six consecutive chiral centers challenged many organic chemists. Chemical ingenuity, implementation of pioneered reactions along with fine chemical transformations allowed not only the rapid construction of the central core but also allowed minor structural revision and paved the information to delineate the absolute stereostructures of these complex polyketide marine natural products. To achieve the central core structure in indoxamycins A-F, reactions like the Ireland-Claisen rearrangement, an enantioselective 1,6-enyne reductive cyclization, and one-pot cascade reactions of 1,2-addition/oxa-Michael/methylenation were employed. Using the chiral pool approach, the readily available R-carvone was employed as a cost-effective starting material to achieve the concise total syntheses of (-)-indoxamycins A and B, in which Pauson-Khand, Cu-catalyzed Michael addition and tandem retro-oxa-Michael addition/1,2-addition/oxa-Michael addition reactions were employed. The antipodes, (+)-indoxamycins can be easily accessed by simply switching to S-carvone as the starting material. Synthetically prepared indoxamycins A-F are devoid of antiproliferative properties, which disagree with the work reported by Sato and co-workers for (-)indoxamycins A and F. Nevertheless, ready access to such complex natural products allows probing the untapped potential biological activities of these polyketides including cytotoxicity. A concise overview of interesting, key chemical transformations including named reactions in establishing the architecture of indoxamycins was compiled to inspire organic chemists and help reinvigorate novel strategies for the asymmetric synthesis as well as the development of novel derivatives of indoxamycins with unique physicochemical and biological properties.

Genome-Directed Discovery of Tetrahydroisoquinolines from Deep-Sea Derived Streptomyces Niveus SCSIO 3406.

Discovery and Efficient Synthesis of a Biologically Active Alkaloid Inspired by Thiostrepton Biosynthesis

Thioquinomycins A-D, Novel Naphthothiophenediones from the Marine-Derived Streptomyces Sp SS17F

New isofuranonaphthoquinones and isoindolequinones from Streptomyces sp. CB01883

Multi-Targeting Exploration of New 2-Aminothiazolyl Quinolones: Synthesis, Antimicrobial Evaluation, Interaction with Dna, Combination with Topoisomerase Iv and Penetrability into Cells

Pyrimidine Nucleosides from Streptomyces Sp. SSA28

Complete Genome Sequence of Streptomyces Sp. HNA39, a New Cyclizidine Producer Isolated from a South China Sea Sediment.

Biosynthesis of Tetrahydroisoquinoline Antibiotics

Nitricquinomycins A-C, Uncommon Naphthopyrrolediones from the Streptomyces Sp. ZS-A45

Discovery and Biosynthetic Origin of Quinolizidomycins A and B, Two Quinolizidine Alkaloids from Streptomyces sp. KIB-1714

Novel antibacterial alkaloids from the Mariana Trench-derived actinomycete Streptomyces sp. SY2255

Medermycin-Type Naphthoquinones from the Marine-Derived Streptomyces Sp XMA39

New analogues of amides and quinolinones produced by Streptomyces sp. YIM S01983

A novel polycyclic quinazoline and three quinolines alkaloids from marine-derived fungus trichoderma longibrachiatum QD01 with anti-bacterial and anti-quorum sensing activities

Streptoindoles A–D, Novel Antimicrobial Indole Alkaloids from the Marine-Associated Actinomycete Streptomyces Sp. ZZ1118

Chlorinated bis-indole alkaloids from deep-sea derived Streptomyces sp. SCSIO 11791 with antibacterial and cytotoxic activities

Synthetic Approaches For Building Tricyclic Cage-Like Motifs Found In Indoxamycins

Evolution of a Synthetic Strategy toward the Syntheses of Bis-tetrahydroisoquinoline Alkaloids

A yeast platform for high-level synthesis of natural and unnatural tetrahydroisoquinoline alkaloids

A yeast platform for high-level synthesis of tetrahydroisoquinoline alkaloids

Biosynthetic Progress of the Tetrahydroisoquinoline Antitumor Antibiotics